Literature DB >> 16350853

Adiponectin induces growth arrest and apoptosis of MDA-MB-231 breast cancer cell.

Jee Hyun Kang1, Yoon Young Lee, Byung Yeon Yu, Beom-Seok Yang, Kyung-Hwan Cho, Do Kyoung Yoon, Yong Kyun Roh.   

Abstract

Recently, it was reported that reduction in serum adiponectin levels is correlated with the incidence of breast cancer. As an effort to explain this, we screened various human breast cancer cell lines to identify those in which proliferation is directly controlled by adiponectin. Among the five tested cell lines, proliferation of MDA-MB-231 cancer cell was significantly suppressed by adiponectin within the range of physiological concentration. Furthermore, prolonged adiponectin treatment caused cell growth arrest and even apoptosis of MDA-MB-231. This result is the first to show that adiponectin can directly control cancer cell growth and provides a rationale for the theory that reduction in plasma adiponectin levels could be a risk factor for breast cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16350853     DOI: 10.1007/bf02978210

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  52 in total

Review 1.  The balance between leptin and adiponectin in the control of carcinogenesis - focus on mammary tumorigenesis.

Authors:  Michael E Grossmann; Margot P Cleary
Journal:  Biochimie       Date:  2012-06-20       Impact factor: 4.079

Review 2.  The role of cytokines in breast cancer development and progression.

Authors:  Marcela Esquivel-Velázquez; Pedro Ostoa-Saloma; Margarita Isabel Palacios-Arreola; Karen E Nava-Castro; Julieta Ivonne Castro; Jorge Morales-Montor
Journal:  J Interferon Cytokine Res       Date:  2014-07-28       Impact factor: 2.607

Review 3.  Adiponectin and breast cancer.

Authors:  Xiuping Chen; Yitao Wang
Journal:  Med Oncol       Date:  2010-07-13       Impact factor: 3.064

4.  Adiponectin represses colon cancer cell proliferation via AdipoR1- and -R2-mediated AMPK activation.

Authors:  A Young Kim; Yun Sok Lee; Kang Ho Kim; Jae Ho Lee; Hee Kyu Lee; Su-Hwa Jang; Seong-Eun Kim; Gha Young Lee; Joo-Won Lee; Sung-Ae Jung; Hee Yong Chung; Sunjoo Jeong; Jae Bum Kim
Journal:  Mol Endocrinol       Date:  2010-05-05

Review 5.  Adipose tissue dysfunction and its effects on tumor metabolism.

Authors:  Jonathan Diedrich; Halina Chkourko Gusky; Izabela Podgorski
Journal:  Horm Mol Biol Clin Investig       Date:  2015-01

6.  Adiponectin receptor expression predicts favorable prognosis in cases of hepatocellular carcinoma.

Authors:  Eun Shin; Young-Dong Yu; Dong-Sik Kim; Nam Hee Won
Journal:  Pathol Oncol Res       Date:  2014-03-12       Impact factor: 3.201

7.  Triple-negative breast cancer and its association with obesity.

Authors:  Heng Sun; Jing Zou; Ling Chen; Xuyu Zu; Gebo Wen; Jing Zhong
Journal:  Mol Clin Oncol       Date:  2017-09-29

8.  Do adipokines underlie the association between known risk factors and breast cancer among a cohort of United States women?

Authors:  Mia M Gaudet; Roni T Falk; Gretchen L Gierach; James V Lacey; Barry I Graubard; Joanne F Dorgan; Louise A Brinton
Journal:  Cancer Epidemiol       Date:  2010-06-26       Impact factor: 2.984

Review 9.  The Role of Adipokines in Breast Cancer: Current Evidence and Perspectives.

Authors:  Gerasimos Socrates Christodoulatos; Nikolaos Spyrou; Jona Kadillari; Sotiria Psallida; Maria Dalamaga
Journal:  Curr Obes Rep       Date:  2019-12

10.  Relationship of serum adiponectin and resistin levels with breast cancer risk.

Authors:  Jee-Hyun Kang; Byung-Yeon Yu; Dae-Sung Youn
Journal:  J Korean Med Sci       Date:  2007-02       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.